Market Tracker

03/24 5:16pm ET

Aevi Genomic Medicine Inc (NASDAQ:GNMX)

1.60
Delayed Data
As of Mar 24
 -0.02 / -1.23%
Today’s Change
1.50
Today|||52-Week Range
6.89
-69.11%
Year-to-Date
Biotech Premarket Movers:
Mar 20 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close1.62
Today’s open1.61
Day’s range1.59 - 1.71
Volume885,508
Average volume (3 months)485,860
Market cap$59.4M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+17.93%
Earnings growth (this year)+6.89%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.70

Competitors

 Today’s
change
Today’s
% change
NTECIntec Pharma Ltd+0.05+0.99%
ZSANZosano Pharma Corp-0.04-2.26%
OREXOrexigen Therapeutic...-0.02-0.50%
NBYNovaBay Pharmaceutic...0.000.00%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$41.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael F. Cola
CFO, Principal Financial &
Accounting Officer
Brian D. Piper
Corporate headquarters
Wayne, Pennsylvania

Forecasts